Furthermore, knockdown of ZNF655 suppressed the progression of glioma cells, which was characterized by reduced proliferation, enhanced apoptosis, cycle repression in G2, inhibition of migration, and weakened tumorigenesis. Here, ZNF655 is linked to central nervous system cancer.